drug

ABI-110

Phase 2updated 5mo ago

by Avirmax Inc

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying ABI-110

phase2Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54-VEGF Trap) in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Including Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV)active not recruitingn=18

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

ABI-110

Phase 2updated 5mo ago

by Avirmax Inc

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying ABI-110

phase2Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54-VEGF Trap) in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Including Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV)active not recruitingn=18

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

ABI-110

all catalysts(0)

Trials studying ABI-110

News(0)

Report a data issue

comments(0)

ABI-110

all catalysts(0)

Trials studying ABI-110

News(0)

Report a data issue

comments(0)